EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Novel ultrasensitive immunoassay for the selective quantification of tau oligomers and related soluble aggregates

Tohidul Islam, Hlin Kvartsberg, Anuradha Sehrawat, Przemysław R Kac, Bruno Becker, Maria Olsson, Eric E Abrahamson, Henrik Zetterberg, Milos D Ikonomovic, Kaj Blennow, Thomas K Karikari iD

Alzheimer's & Dementia · 2024

DOI: 10.1002/alz.13711 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2024. Verfasst von Tohidul Islam und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölnd…. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIH HHS, NIA NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Tau aggregation into paired helical filaments and neurofibrillary tangles is characteristic of Alzheimer's disease (AD) and related disorders. However, biochemical assays for the quantification of soluble, earlier‐stage tau aggregates are lacking. We describe an immunoassay that is selective for tau oligomers and related soluble aggregates over monomers. METHODS A homogeneous (single‐antibody) immunoassay was developed using a novel anti‐tau monoclonal antibody and validated with recombinant and brain tissue–derived tau. RESULTS The assay signals were concentration dependent for recombinant tau aggregates in solution but not monomers, and recognized peptides within, but not outside, the aggregation‐prone microtubule binding region. The signals in inferior and middle frontal cortical tissue homogenates increased with neuropathologically determined Braak staging, and were higher in insoluble than soluble homogenized brain fractions. Autopsy‐verified AD gave stronger signals than other neurodegenerative diseases. DISCUSSION The quantitative oligomer/soluble aggregate‐specific assay can identify soluble tau aggregates, including oligomers, from monomers in human and in vitro biospecimens. Highlights The aggregation of tau to form fibrils and neurofibrillary tangles is a key feature of Alzheimer's disease. However, biochemical assays for the quantification of oligomers/soluble aggregated forms of tau are lacking. We developed a new assay that preferentially binds to soluble tau aggregates, including oligomers and fibrils, versus monomers. The assay signal increased corresponding to the total protein content, Braak staging, and insolubility of the sequentially homogenized brain tissue fractions in an autopsy‐verified cohort. The assay recognized tau peptides containing the microtubule binding region but not those covering the N‐ or C‐terminal regions only.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseHumanstau ProteinsNeurofibrillary TanglesImmunoassayPeptides

Stichwörter der Autor:innen

Alzheimer's diseaseimmunoprecipitationmicrotubule binding regionsoluble tau aggregatestau oligomers

Substanzen

tau ProteinsPeptides

Autor:innen und Institutionen

  • Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
  • Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
  • Department of Psychiatry, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Department of Neurology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Geriatric Research Education and Clinical Center, VA Pittsburgh HS, Pittsburgh, Pennsylvania, USA.
  • Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK.

ORCID-Profile: Thomas K Karikari

Förderung

  • NIH HHS
  • NIA NIH HHS
  • NINDS NIH HHS
  • Alzheimer's Association
  • Vetenskapsrådet
  • Alzheimer's Drug Discovery Foundation
  • Familjen Erling-Perssons Stiftelse
  • UK Dementia Research Institute

Zitieren

APA

Islam, T., Kvartsberg, H., Sehrawat, A., Kac, P. R., Becker, B., Olsson, M., Abrahamson, E. E., Zetterberg, H., Ikonomovic, M. D., Blennow, K., & Karikari, T. K. (2024). Novel ultrasensitive immunoassay for the selective quantification of tau oligomers and related soluble aggregates. Alzheimer's & Dementia. https://doi.org/10.1002/alz.13711

Vancouver

Islam T, Kvartsberg H, Sehrawat A, Kac PR, Becker B, Olsson M, et al. Novel ultrasensitive immunoassay for the selective quantification of tau oligomers and related soluble aggregates. Alzheimer's & Dementia. 2024. doi:10.1002/alz.13711

BibTeX
@article{Islam2024,
  author = {Islam, Tohidul and Kvartsberg, Hlin and Sehrawat, Anuradha and Kac, Przemysław R and Becker, Bruno and Olsson, Maria and Abrahamson, Eric E and Zetterberg, Henrik and Ikonomovic, Milos D and Blennow, Kaj and Karikari, Thomas K},
  title = {Novel ultrasensitive immunoassay for the selective quantification of tau oligomers and related soluble aggregates},
  journal = {Alzheimer's & Dementia},
  year = {2024},
  doi = {10.1002/alz.13711}
}
Kostenlos starten →